Resonance Health Limited (ASX:RHT) has lodged a cleansing notice under section 708A(5)(e) of the Corporations Act 2001 following the completed issue of 83,333,320 fully paid ordinary shares at $0.072 per share to institutional, professional and sophisticated investors by way of placement.

Key Points

  • Resonance Health completed the placement of 83,333,320 fully paid ordinary shares at $0.072 per share.
  • The shares were issued to institutional, professional and sophisticated investors without disclosure under Part 6D.2 of the Corporations Act.
  • The placement was previously announced on 27 October 2026.
  • The cleansing notice was filed on 6 November 2026 pursuant to section 708A(5)(e) of the Corporations Act 2001.

Placement Completion and Share Issuance Details

Resonance Health Limited disclosed on 6 November 2026 that it has completed the issue of 83,333,320 fully paid ordinary shares in the capital of the company at a price of $0.072 per share. The shares were placed with institutional, professional and sophisticated investors. The placement had been previously announced on 27 October 2026. The shares were issued without disclosure to investors under Part 6D.2 of the Corporations Act 2001, which triggered the requirement for the company to lodge a formal cleansing notice with the ASX.

Cleansing Notice Pursuant to Section 708A(5)(e)

The cleansing notice filed by Resonance Health states that, as at the date of the notice, the company has complied with the provisions of Chapter 2M of the Corporations Act as they apply to the company, and with sections 674 and 674A of the Corporations Act. The company further confirmed that, as at the date of the notice, there is no information constituting "excluded information" as defined in section 708A(7) of the Corporations Act that is required to be disclosed by the company in accordance with section 708A(8) of the Corporations Act.

Authorisation of the Filing

The filing states that the notice was authorised for release in accordance with the delegated authority of the Board of Directors of Resonance Health Limited. The company is incorporated with ABN 96 006 762 492 and is headquartered at 141 Burswood Road, Burswood, Western Australia. The release was made by Andrew Harrison, who holds the position of Managing Director and Chief Executive Officer of Resonance Health Limited.